Articles

Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells

Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia;School of Medicine, University of Adelaide, Australia
Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia;School of Medicine, University of Adelaide, Australia
Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia;School of Medicine, University of Adelaide, Australia
Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia
Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia
Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia
Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia;School of Medicine, University of Adelaide, Australia
Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia;School of Medicine, University of Adelaide, Australia;Department of Haematology, SA Pathology, Adelaide, Australia;Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia;School of Medicine, University of Adelaide, Australia;Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
Vol. 102 No. 5 (2017): May, 2017 https://doi.org/10.3324/haematol.2016.153270